Building on the experience of the EU Task Force for Industrial Scale-up of COVID-19 vaccines, the European Commission will facilitate cooperation between actors in the supply chain to ensure that available therapeutics are produced in sufficient quantity as soon as possible. In the context of a surge in demand, it remains crucial to ensure the speedy production of current and new therapeutics against COVID-19. To support the industry, the Commission organises the pan-EU matchmaking events for all supply chain actors, so that they find solutions for the bottlenecks encountered.
Medicines for COVID-19 are still in the development phase. Therefore, the objective of the event is to help accelerate the development of new and repurposed medicines for COVID-19 therapeutics, i.e. medicines specifically developed for an indication in treatment of COVID-19, at all stages of COVID-19 disease and mobilise the EU pharma manufacturing capacity for their potential production.
The target group is the entire EU COVID-19 therapeutics value chain starting with researchers and developers, through manufacturing companies and representatives of the hospitals, who apply such therapeutics to their patients. The providers of ancillary functions such as clinical trials services, accessories suppliers (e.g. vials, syringes, tubes etc.), funding providers and public procurers will also be targeted to take part in the event.
The event will take place virtually on 12th and 13th July 2021. 12th July will start with a half-day seminar setting the scene with a welcome by Commissioner Breton and Commissioner Kyriakides.
How to apply?
In order to apply to the event, European companies must comply with the requirements stated in the event’s Call for Expression of Interest. Register until June 25.
Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.
Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.
Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.
The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.
Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.
Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.